GlaxoSmithKline "deliberately" discontinued a widely-used asthma medication in order to reap profits and families suffered, Arizona lawsuit says ...
GSK has developed a new propellant technology ... used as a rescue medication by around 35 million people with asthma around the world. Inhalers are also a major contributor to the carbon ...
United Health Group’s pharmacy benefit manager, Optum Rx, stopped covering Cole Schmidtknecht’s ‘life-changing’ inhaler, suit ...
A young Wisconsin man died from an asthma attack after the price of his inhaler skyrocketed nearly $500, according to a ...
Arizona sued drug manufacturer GlaxoSmithKline over what it calls deceptive practices involving the inhaled corticosteroid Flovent that endangered asthma patients. The lawsuit filed Thursday in ...
Arizona Attorney General Kris Mayes on Thursday sued drug producer GlaxoSmithKline (GSK) for harm done to asthma patients by discontinuing a long-time product.
Vantage Market Research is pleased to announce the publication of its latest report, Asthma and COPD Drugs Market. This ...
We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Analysts. In this article, we are going ...
GSK's revenue and EPS exceeded my expectations and those of analysts. Check out the reasons why I am upgrading GSK stock's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results